Prudent Man Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Hold
84
– – ﹤0.01% 96
2026
Q1
$11.6K Hold
84
– – ﹤0.01% 97
2025
Q4
$11.6K Hold
84
– – ﹤0.01% 96
2025
Q3
$8.18K Hold
84
– – ﹤0.01% 96
2025
Q2
$8.18K Hold
84
– – ﹤0.01% 96
2025
Q1
$8.18K Hold
84
– – ﹤0.01% 96
2024
Q4
$8.18K Buy
+84
New +$8.96K ﹤0.01% 96

Other funds holding NVS

Prudent Man Investment Management's NVS Position: Q2 2026 in Review

Prudent Man Investment Management held its Novartis (NVS) position steady in Q2 2026 at 84 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #96.

Prudent Man Investment Management first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,626 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Prudent Man Investment Management held 84 shares of Novartis worth $11.6K as of Q2 2026.
  • Prudent Man Investment Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Prudent Man Investment Management's portfolio in Q2 2026, its #96 holding.
  • Prudent Man Investment Management first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,626 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Prudent Man Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.